DIABETES DRUG
Expensive insulin
More than 90 years after it was first discovered, and despite being listed as an essential medicine by the WHO since 2007, insulin remains expensive and beyond the reach of many with Type 1 and Type 2 diabetes, say experts writing in
SUBSTANCE ABUSE
FDA on rising opioid use
The US Food and Drug Administration is deeply concerned about the growing epidemic of opioid abuse, dependence and overdose in the US. The agency has developed a comprehensive action plan to take concrete steps to reduce the impact of opioid abuse on families and communities. The agency is committing to work more closely with its advisory committees before making critical product and labelling decisions; enhancing safety labelling; requiring new data; and seeking to improve treatment of both addiction and pain. But the FDA will also re-examine the risk-benefit paradigm for opioids and consider the wider public health effects.